Video

ESC 2018: The GLOBAL LEADERS Trial

Published: 14 Sep 2018

  • Views:

    Views Icon 76

  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

 

Prof Patrick Serruys (Imperial College, London, UK) discusses a randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy (GLOBAL LEADERS).

Filmed on-site at ESC 2018, Munich.